Neoadjuvant CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer: CONVERT Phase III Tr

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 19 Feb 2026. The item focuses on Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial. Review the original article for the full source wording and details.